Small therapeutic molecules for the treatment of inflammatory bowel disease.

van Deventer, S J H · Gut · 2002

review · Level V

Where this comes from

Abstract

New therapies for inflammatory bowel disease are needed, because standard therapies fail to induce remission in about 30% of patients, and because of the relative inefficacy of current maintenance therapies. This review summarises the current status of the development of small therapeutic molecules for inflammatory bowel disease.

Medical subject headings